73
Analysis of factors influencing costs in the preferential drug provision system for children with type 1 diabetes mellitus
The study substantiates a methodological approach to integrating administrative databases for comprehensive analysis of factors determining costs in the
Preferential Drug Provision System for children with type 1 diabetes mellitus during the period from 2022 to 2024. The research analyzed data from 22.8
thousand prescriptions for drugs and medical devices for a total of 163.7 million rubles. It was found that the greatest impact on costs is exerted by the
use of modern medical technologies: application of continuous glucose monitoring systems (+402.0%) and insulin pump therapy (+131.0%). The smallest (+25.2%) but stable influence on costs was demonstrated in the presence of complications. The developed multivariate regression model explains 59.1% of cost variability, confirming the necessity of considering patients’ clinical characteristics and applied medical technologies when planning healthcare system resources.
Скорее всего ваш браузер не поддерживает PDF и Adobe Reader, нажмите здесь, чтобы просмотреть PDF
Bibliography link:
Grazhdankina A.A., Karakulova E.V. Analysis of factors influencing costs in the preferential drug provision system for children with type 1 diabetes mellitus // Pharmacoeconomics: theory and practice. - 2025. - Vol.13, №2. P. 5-12 DOI: https://doi.org/10.30809/phe.3.2025.1
Comments0